Dec 2007
Non-invasive FibroTest and FibroScan Predict
Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis
C Patients
Non-invasive screening for liver fibrosis in
HIV/HCV coinfected patients
Nov 2007
58th Annual Nov 2007 AASLD Meeting
Disease Progression
Various factors that influence HCV disease progression
including steatosis, obesity, insulin resistance, diabetes, race/ethnicity,
and general studies on disease progression
AASLD:
Higher Caffeine Consumption is associated with Milder
Fibrosis in patients with Chronic Liver Diseases
MAINTENANCE THERAPY FOUND INEFFECTIVE HALT-C STUDY
Clinical Relevance of Rapid Virological Response (RVR)
in Decompensated HCV-Related Cirrhosis Treated With Peginterferon and
Ribavirin
Long-term, Low-Dose Treatment with Pegylated
Interferon Alfa-2b (PegIntron) Monotherapy Leads to a Reduction in Fibrosis
and Inflammatory Scores in Prior Non-responders
What is the best non invasive method for early
prediction of cirrhosis in chronic hepatitis C? Prospective comparison
between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio,
platelet count and Fibrotest) -
Long-Term, Low-Dose Treatment With Pegylated
Interferon alfa-2b Leads to a Significant Reduction in Fibrosis and
Inflammatory Scores in Chronic Hepatitis C Nonresponder Patients With
Fibrosis or Cirrhosis
Treatment of Hepatitis C Patients with Child A and B
cirrhosis with Consensus Interferon and Ribavirin in a Low Ascending Dosing
Regimen Leads to Significant Viral Elimination Rates
MRI Predicts Liver Fibrosis, Study Says
HCV Advocate’s AASLD Conference coverage
Oct-Sept-June
Marianne Faithfull Has Hepatitis C -
Insulin Resistance Predicts Liver Fibrosis in Patients
with Hepatitis C or Non-alcoholic Fatty Liver Disease
Ultrasound-Based Transient Elastography for the Detection of Hepatic
Fibrosis: Systematic Review and Meta-analysis
-
Stiffness and Impedance: The New Liver Biomarkers Editorial
Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis
C by Splenic Doppler Impedance Index -
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
-
Factors Associated with Long-term Liver Complications
after Spontaneous HCV Clearance or Successful Treatment
CAD Increases Accuracy Of Diagnosing Liver
Fibrosis
Natural History of Hepatitis C in Patients
with Severe Liver Fibrosis
Stanford researchers develop new genetic marker test
to predict likelyhood for progression to cirrhosis of hcv patients:
Liver Fibrosis Is Associated with Decreased
Peripheral Platelet Count in Patient
Interesting link of Ablation of 'inoperable' Liver
Tumors.
Ursodeoxycholic Acid May Reduce Liver Inflammation in
Patients with Chronic Hepatitis C
FIB-4: An Inexpensive and Accurate Marker of Liver
Fibrosis in Patients with Hepatitis C
Non-Invasive and Inexpensive Fibrosis
Evaluation for HCV
The Pros and Cons of Using Marijuana with
Hepatitis C
Comparison of 6 Non-invasive Measures for Diagnosing
Liver Fibrosis in Hepatitis C Patients
Reversibility of hepatic fibrosis and cirrhosis-is it all hype? Editorial
Glucose Intolerance Associated with Advancing Liver
Disease (Fibrosis)
Milk Thistle (Silymarin) Demonstrates
Anti-inflammatory and Anti-HCV Activity in a Laboratory Study
A Follow-up Week 12 Viral Count Is Useful in
Predicting SVR and Is 100% Accurate in Patients without Cirrhosis
MAY
Statins May Improve Liver Fibrosis
-
The APRI may be enhanced by the use of the FIBROSpect
II in the estimation of fibrosis in
chronic hepatitis C.
Response to PegIntron/ribavirin Leads to Stabilization
of Fibrosis in Liver Transplant Recipients
Celera Publishes Data Validating Cirrhosis
Risk Score As a Predictor of Cirrhosis in Chronic Hepatitis C Patients
April-March
Stem Cells Speed Growth Of Healthy Liver
Tissue
Schering's Experimental Oral HCV Protease Inhibitor
Boceprevir Appears Safe in Patients with Varying Degrees of Liver Impairment
-
Researchers Identify Critical Receptor In
Liver Regeneration
Interferon Gamma Does Not Reverse Fibrosis in
Hepatitis C Patients with Advanced Liver Disease
Health-related Quality of Life in Chronic Hepatitis C
Patients with Advanced Fibrosis
Heavy Alcohol Use Worsens Disease Progression in Women
with Chronic Hepatitis C
February
Liver Stiffness Measurement Versus Clinicians' Prediction or Both for the
Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C
-
Are Noninvasive Liver Fibrosis Tests Ready
for Use? There are lots of questions. Prospective comparison of six
non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis
C
New Index for Assessing Liver Fibrosis
Risk Factors for Liver Fibrosis in Veterans with
Chronic Hepatitis
Noninvasive Markers of Liver Fibrosis
Efficacy of Low-dose versus Standard Dose Pegylated
Interferon Alfa-2b (PegIntron) plus Ribavirin for Treatment of Chronic
Hepatitis C with Severe Fibrosis
January
Treatment of Hepatitis C in Patients with Advanced
Fibrosis or Cirrhosis
Iron Accumulation Gene Mutations and Liver Fibrosis in
Patients with Hepatitis C
Impact of Disease Severity on HCV Treatment Outcomes
in HALT-C Trial
News Archives
2008
2006
2005-2003
|
